# PET Prostate-Specific Membrane Antigen Radiopharmaceuticals Amend for Questions and Answers

Canonical: https://abierto.us/opportunities/36c25226q0211

- Solicitation number: 36C25226Q0211
- Notice type: Combined synopsis and solicitation
- Status: Closed. Deadline was January 26, 2026 at 5:00 PM EST
- Department: Department of Veterans Affairs
- Contracting office: 252-Network Contract Office 12 (36C252)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- Place of performance: Chicago, Illinois
- County: Cook County (FIPS 17031). https://abierto.us/counties/cook-county-il-17031
- City: Chicago. https://abierto.us/cities/chicago-il-1714000
- First posted: January 16, 2026
- Last posted: January 23, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/79d0e5ccd8604afc894314ea0311fa7e/view

## Description

PET Prostate-Specific Membrane Antigen (PSMA) Radiopharmaceuticals 36C25226Q0211 Questions & Answers Will the awarded contractor assume all responsibility and accountability for providing contingency plans, prior to the award, to include alternative sources, in advance of any event in which local radio pharmacies are unable to provide routine delivery of Prostate Specific Membrane Antigen (PSMA) diagnostic imaging products?

Yes, the awarded contractor will be expected to assume full responsibility and accountability for providing contingency plans prior to the award. Typically, PSMA patients require flexibility in scheduling daily appointments. What is the specific requirement to provide PSMA for afternoon deliveries on the same day? All orders will be placed ahead of time as part of routine scheduling.

In the event of a same-day order for an afternoon delivery, the order will be submitted before 10:00 AM (or another mutually agreed-upon cut-off time) to allow sufficient time for dose preparation and delivery logistics. There are currently, multiple FDA approved PSMA products available. Is this RFQ a Sole Source request? RFQ is not a Sole Source.

**Subject Line:** "PET Prostate-Specific Membrane Antigen (PSMA) Radiopharmaceuticals"- fluciclovine F 18 (Axumin) gallium-68 PSMA-11 (Illuccix, Locametz) fluorine 18 (F 18) labeled agents piflufolastat F 18 (Pylarify) flotufolastat F 18 (Posluma)

## Publications

- January 16, 2026: Combined synopsis and solicitation, due January 26, 2026 at 5:00 PM EST. Notice 72450d10b29e44438671479e863704f7. https://sam.gov/workspace/contract/opp/72450d10b29e44438671479e863704f7/view
- January 16, 2026: Combined synopsis and solicitation, due January 26, 2026 at 5:00 PM EST. Notice e6a3766bacd44ac9a9dcd949bb44620f. https://sam.gov/workspace/contract/opp/e6a3766bacd44ac9a9dcd949bb44620f/view
- January 23, 2026: Combined synopsis and solicitation, due January 26, 2026 at 5:00 PM EST. Notice 79d0e5ccd8604afc894314ea0311fa7e. https://sam.gov/workspace/contract/opp/79d0e5ccd8604afc894314ea0311fa7e/view

## Points of contact

- Stacy Massey, Contracting Officer, Stacy.Massey@va.gov, 4148448400

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/36c25226q0211.